Publication:
Antimetabolite cancer drug gemcitabine selectively impacts preantral and antral follicle cohorts in the ovary as evidenced by quantitatively histomorphometric, hormonal and cell viability markers

Simple item page
dc.conference.dateJUN 29-JUL 02, 2014
dc.conference.locationMunich, GERMANY
dc.conference.organizer30th Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
dc.contributor.coauthorN/A
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorEryılmaz, Baldan
dc.contributor.kuauthorKaranfil, Işıl
dc.contributor.kuauthorKılıç, Yağmur
dc.contributor.kuauthorÖktem, Özgür
dc.contributor.kuauthorÖzkanbaş, Necmettin Can
dc.contributor.kuauthorŞahin, Gizem Nur
dc.contributor.kuauthorYılmaz, Pelinsu
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:27:58Z
dc.date.issued2014
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.openaccessNO
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipStudy funding/competing interest(s): Funding by University(ies), Koc University School of Medicine
dc.description.studentonlypublicationNo
dc.description.studentpublicationYes
dc.description.versionN/A
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1093/humrep/29.Supplement_1.1
dc.identifier.eissn1460-2350
dc.identifier.embargoN/A
dc.identifier.endpage169
dc.identifier.issn0268-1161
dc.identifier.issueSupplement 1
dc.identifier.startpage166
dc.identifier.urihttps://doi.org/10.1093/humrep/29.Supplement_1.1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/11806
dc.identifier.volume29
dc.identifier.wos000359745300393
dc.keywordsGemcitabine
dc.keywordsOvarian follicles
dc.keywordsChemotherapy
dc.keywordsGonadotoxicity
dc.keywordsCancer drug
dc.language.isoeng
dc.publisherOxford Univ Press
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofHuman Reproduction
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectObstetrics
dc.subjectGynecology
dc.subjectReproductive biology
dc.titleAntimetabolite cancer drug gemcitabine selectively impacts preantral and antral follicle cohorts in the ovary as evidenced by quantitatively histomorphometric, hormonal and cell viability markers
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorKılıç, Yağmur
local.contributor.kuauthorŞahin, Gizem Nur
local.contributor.kuauthorKaranfil, Işıl
local.contributor.kuauthorEryılmaz, Baldan
local.contributor.kuauthorYılmaz, Pelinsu
local.contributor.kuauthorÖzkanbaş, Necmettin Can
local.contributor.kuauthorÖktem, Özgür
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext